Stanford University
Showing 7,901-8,000 of 36,328 Results
-
Taran Driver
Lead Scientist, SLAC National Accelerator Laboratory
BioI gained my PhD from the Blackett Laboratory Laser Consortium at Imperial College London, where my primary research project was the development of a new type of mass spectrometry for the structural analysis of protein, DNA and RNA molecules. This technology is known as two-dimensional partial-covariance mass spectrometry (2D PC MS). Here at Stanford I work at the Linac Coherent Light Source (LCLS), using the attosecond X-ray pulses produced by the newly developed XLEAP mode to study ultrafast electronic processes in molecules. We are developing and using new spectroscopic methods in the attosecond regime to observe the motion of electrons in complex molecular systems on their natural timescale. This helps us to understand how the coherent quantum dynamics of these electronic systems affect subsequent chemical motion.
-
Ron Dror
Cheriton Family Professor and Professor, by courtesy, of Structural Biology and of Molecular & Cellular Physiology
Current Research and Scholarly InterestsMy lab’s research focuses on computational biology, with an emphasis on 3D molecular structure. We combine two approaches: (1) Bottom-up: given the basic physics governing atomic interactions, use simulations to predict molecular behavior; (2) Top-down: given experimental data, use machine learning to predict molecular structures and properties. We collaborate closely with experimentalists and apply our methods to the discovery of safer, more effective drugs.
-
David Drover
Professor of Anesthesiology, Perioperative and Pain Medicine (MSD), Emeritus
Current Research and Scholarly InterestsField of clinical pharmacology. This involves analysis of what the body does to a drug (pharmacokinetics) and how exactly a specific drug affects the body (pharmacodynamics). His research starts at the level of new drug development with detailed analysis of the pharmacokinetics and pharmacodynamics of a medication.
-
Shaul Druckmann
Associate Professor of Neurobiology, of Psychiatry and Behavioral Sciences and, by courtesy, of Electrical Engineering
Current Research and Scholarly InterestsOur research goal is to understand how dynamics in neuronal circuits relate and constrain the representation of information and computations upon it. We adopt three synergistic strategies: First, we analyze neural circuit population recordings to better understand the relation between neural dynamics and behavior, Second, we theoretically explore the types of dynamics that could be associated with particular network computations. Third, we analyze the structural properties of neural circuits.
-
Maurice L. Druzin
Professor of Obstetrics and Gynecology (Maternal Fetal Medicine and Obstetrics), Emeritus
Current Research and Scholarly InterestsAntepartum and intrapartum fetal monitoring Prenatal diagnosis Medical complications of pregnancy, particularly: SLE, hypertension, diabetes, malignancy A.
-
Tianwei Du
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioDr. Du's clinical interests focus on providing evidence-based treatment to individuals with emotion dysregulation, interpersonal difficulties, and/or complex trauma. She is also passionate about addressing diversity factors in clinical work. Dr. Du provides services in the Dialectical Behavior Therapy (DBT) Adult Program, Stanford Mental Health for Asians Research and Treatment (SMHART) Clinic, and the Anxiety and Depression Adult Psychological Treatment (ADAPT) Clinic. Dr. Du is a bilingual clinician speaking English and Mandarin.
Dr. Du's research focuses on exploring the roles of interpersonal processes and personality in psychopathology, and she has published widely on this topic. Dr. Du also participated in a variety of clinical trials to help develop and improve evidence-based interventions for individuals with complex clinical presentations and populations with limited access to mental health care. -
Justin Du Bois
Henry Dreyfus Professor of Chemistry and Professor, by courtesy, of Chemical and Systems Biology
BioResearch and Scholarship
Research in the Du Bois laboratory spans reaction methods development, natural product synthesis, and chemical biology, and draws on expertise in molecular design, molecular recognition, and physical organic chemistry. An outstanding goal of our program has been to develop C–H bond functionalization processes as general methods for organic chemistry, and to demonstrate how such tools can impact the logic of chemical synthesis. A second area of interest focuses on the role of ion channels in electrical conduction and the specific involvement of channel subtypes in the sensation of pain. This work is enabled in part through the advent of small molecule modulators of channel function.
The Du Bois group has described new tactics for the selective conversion of saturated C–H to C–N and C–O bonds. These methods have general utility in synthesis, making possible the single-step incorporation of nitrogen and oxygen functional groups and thus simplifying the process of assembling complex molecules. To date, lab members have employed these versatile oxidation technologies to prepare natural products that include manzacidin A and C, agelastatin, tetrodotoxin, and saxitoxin. Detailed mechanistic studies of metal-catalyzed C–H functionalization reactions are performed in parallel with process development and chemical synthesis. These efforts ultimately give way to advances in catalyst design. A long-standing goal of this program is to identify robust catalyst systems that afford absolute control of reaction selectivity.
In a second program area, the Du Bois group is exploring voltage-gated ion channel structure and function using the tools of chemistry in combination with those of molecular biology, electrophysiology, microscopy and mass spectrometry. Much of this work has focused on studies of eukaryotic Na and Cl ion channels. The Du Bois lab is interested in understanding the biochemical mechanisms that underlie channel subtype regulation and how such processes may be altered following nerve injury. Small molecule toxins serve as lead compounds for the design of isoform-selective channel modulators, affinity reagents, and fluorescence imaging probes. Access to toxins and modified forms thereof (including saxitoxin, gonyautoxin, batrachotoxin, and veratridine) through de novo synthesis drives studies to elucidate toxin-receptor interactions and to develop new pharmacologic tools to study ion channel function in primary cells and murine pain models. -
Monica M. Dua, MD
Clinical Professor, Surgery - General Surgery
Current Research and Scholarly InterestsTechnical aspects of minimally invasive pancreatic and liver surgery
Minimally invasive strategies for the management of pancreatic necrosis
Management of severe acute pancreatitis – academic vs community treatment
Multidisciplinary treatment of HCC; institutional barriers to appropriate referral/ care
Endocrine/exocrine insufficiency after pancreatectomy; volumetric assessment
Natural history and management of pancreatic cysts -
Junting Duan
Ph.D. Student in Management Science and Engineering, admitted Autumn 2020
BioJunting Duan is a PhD candidate in the Department of Management Science and Engineering (MS&E) at Stanford University. Prior to joining Stanford, she received her B.S. in Mathematics and Applied Mathematics from Peking University in 2020.
Junting's research interests lie broadly in data-driven decision-making, focusing on statistical inference and machine learning, with applications to causal inference and finance. Her research develops new methodologies with rigorous statistical foundations that enable reliable decision-making with complex and imperfect data, and lies at the intersection of (1) statistical learning for high-dimensional data; (2) causal inference; and (3) machine learning for finance and risk management. Her work has been recognized through publications and revisions at top journals including Management Science and the Journal of Econometrics, as well as invitations to present at major conferences such as the American Economic Association Annual Meeting, the NBER-NSF Time-Series Conference, the NBER Forecasting & Empirical Methods Conference, and the INFORMS Annual Meeting.
Visit her personal website for more details: https://juntingduan.com. -
Dawn Duane
Clinical Professor, Pediatric Neurology
Clinical Professor (By courtesy), PediatricsCurrent Research and Scholarly InterestsI am a general pediatric neurologist. My interest is in clinical diagnosis and treatment of common neurologic diseases in pediatric patients and teaching feature doctors, neurologists and pediatric neurologists about pediatric neurology.
-
Catherine Duarte
Assistant Professor of Epidemiology and Population Health
BioDr. Catherine Duarte is an Assistant Professor in the Department of Epidemiology & Population Health at Stanford University’s School of Medicine. She received her PhD in Epidemiology from the University of California, Berkeley School of Public Health and her Master of Science in Social and Behavioral Sciences from the Harvard T.H. Chan School of Public Health. Duarte’s work evaluates upstream drivers of overall risk for, and heterogeneity in, lifecourse health. Specifically, she examines how education and legal system policy and practice exposures in early life may shape population health and health inequity, with an emphasis on cognitive aging and dementia outcomes in midlife and older age. In doing so, her work aims to contribute to systems-level interventions designed to support population health and wellbeing for collective thriving.
-
Anne Dubin
Endowed Professor of Pediatric Cardiology
Current Research and Scholarly InterestsArrhythmia management in pediatric heart failure, especially resynchronization therapy in congenital heart disease,Radio frequency catheter ablation of pediatric arrhythmias,
-
Anthony DuBose
Clinical Associate Professor, Medicine - Primary Care and Population Health
Current Research and Scholarly InterestsSoft tissue musculoskeletal injuries with focus on repetitive strain injuries
-
Imee Diego DuBose
Director, Alumni Education, Alumni Education Admin
Current Role at StanfordDirector, Alumni Education
-
Alfredo Dubra, PhD
Professor of Ophthalmology
Current Research and Scholarly InterestsOur lab seeks to help the early diagnosing and monitoring progression of ocular, vascular, neurodegenerative and systemic diseases through novel non-invasive optical ophthalmic imaging. We pursue this goal through a multidisciplinary approach that integrates optics, computer science, vision science, electrical engineering and other engineering disciplines.
-
Piotr Dubrowski
Clinical Instructor, Radiation Oncology - Radiation Physics
BioPiotr Dubrowski is a Canadian trained and board-certified Therapy Medical Physicist. Throughout his career Piotr has had the opportunity to bring several new Cancer Clinics operational from the ground up, where he was able to hone a broad, systems-approach to Radiation Oncology. He was recently promoted to Associate Quality Director of Physics responsible for improving patient safety and workflow/technology improvements across a wide cancer care network. Piotr’s research interests focus mainly on improving the treatment planning process and increasing clinic safety through software development and hardware 3D-print prototyping. Additionally, Piotr has sought out opportunities to give back to the Global community with participation in the Stanford Global Radiation Oncology Outreach efforts expanding education and access to care in Tanzania and Kenya and throughout the developing world via online Radiation Therapy courses.
-
John Duchi
Associate Professor of Statistics, of Electrical Engineering and, by courtesy, of Computer Science
Current Research and Scholarly InterestsMy work spans statistical learning, optimization, information theory, and computation, with a few driving goals: 1. To discover statistical learning procedures that optimally trade between real-world resources while maintaining statistical efficiency. 2. To build efficient large-scale optimization methods that move beyond bespoke solutions to methods that robustly work. 3. To develop tools to assess and guarantee the validity of---and confidence we should have in---machine-learned systems.
-
Ramzi Emanuel Dudum
Member (Postdoc), Cardiovascular Institute
BioDr. Dudum is a cardiologist and population health expert working to develop novel risk prediction methods and implementation strategies to create practices and systems that allow for reductions in cardiovascular disease. He completed a Masters in Public Health at Johns Hopkins concentrating in epidemiology and biostatistics and a Doctorate of Medicine at George Washington University.
He completed internal medicine residency training as part of the Osler Medical Service, where he worked under the mentorship of Drs. Roger Blumenthal and Michael Blaha to study improving cardiovascular risk prediction and coronary artery calcium. Given his focus on population health and implementation science, he also helped launch and refine risk adjustment tools and implemented guideline-directed medical care pathways. During his time there, he was recognized for his clinical acumen and dedication to patient care.
He came to Stanford for his cardiovascular medicine fellowship and continued research in coronary artery calcium under the mentorship of Drs. David Maron and Fatima Rodriguez while also conducting cardiovascular health implementation science work under the mentorship of Dr. Steve Asch. He serves as the co-investigator of a prospective randomized trial testing the effects of notification of incidental coronary artery calcium on statin initiation rates among those with and without cardiovascular disease (NCT 05588895). He has worked with hospital leaders to implement digital health and artificial intelligence tools, creating the infrastructure for the prospective use of AI-algorithms on radiology studies. As a preventive cardiologist and population health expert, he leads efforts in the preventive cardiology section related to improving cardiovascular health. -
Beth Duff-Brown
Communications Manager, Health Policy
Current Role at StanfordCommunications Manager for the Center for Health Policy in the Freeman Spogli Institute for International Studies and the Department of Health Policy in the School of Medicine.
-
Mark Duggan
Wayne and Jodi Cooperman Professor and Senior Fellow at the Stanford Institute for Economic Policy Research
BioMark Duggan is a Professor of Economics at Stanford University and a Research Associate at the National Bureau of Economic Research. He received his B.S. and M.S. degrees in Electrical Engineering at M.I.T. in 1992 and 1994, respectively, and his Ph.D. in Economics from Harvard University in 1999. He currently is a Co-Editor at the American Economic Journal: Economic Policy and was previously a Co-Editor at the Journal of Public Economics. Before arriving to Stanford in the summer of 2014, Duggan served on the faculty at the University of Pennsylvania's Wharton School (2011-14), the University of Maryland's Economics Department (2003-11), and the University of Chicago's Economics Department (1999-2003).
Professor Duggan's research focuses primarily on the effect of government expenditure programs such as Social Security, Medicare, and Medicaid on the behavior of individuals and firms. Some of his more recent research is exploring the effect of federal disability programs on the labor market and of changes to the Medicare and Medicaid programs on the cost and quality of health care. He is also estimating the effect of patent reforms in India on the price and utilization of pharmaceutical treatments. His research has been published in leading academic journals including the American Economic Review, the Journal of Political Economy, and the Quarterly Journal of Economics and has been featured in outlets such as The Economist, the New York Times, and the Wall Street Journal.
Professor Duggan was the 2010 recipient of the ASHEcon Medal, which is awarded every two years by the American Society of Health Economists to the economist aged 40 and under in the U.S. who has made the most significant contributions to the field of health economics. Along with his co-author Fiona Scott Morton, he received the National Institute for Health Care Management's 2011 Health Care Research Award for their work on Medicare Part D. He was a Fellow of the Alfred P. Sloan Foundation from 2004 to 2006 and a Visiting Fellow at the Brookings Institution from 2006 to 2007. His research has been funded by the National Science Foundation, the National Institutes of Health, the Social Security Administration, and the Robert Wood Johnson Foundation. Duggan served from 2009 to 2010 as the Senior Economist for Health Care Policy at the White House Council of Economic Advisers and has also been an Expert Witness for the U.S. Department of Justice.
